IBSA Institut Biochimique

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, IBSA Institut Biochimique sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials none currently recruiting 6 completed later-stage tilt upper quartile by trial count

IBSA Institut Biochimique: 8 sponsored US clinical trials, none currently recruiting.

IBSA Institut Biochimique sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. 8 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Athletic Injuries, with 1 trials.

Upper-quartile sponsor footprint

IBSA Institut Biochimique sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

8 total, page 1 of 1

ACTIVE NOT RECRUITING Phase 3

Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.

NCT04549116
COMPLETED Phase 3

A New Sildenafil Oral Film in Patients With Erectile Dysfunction

NCT05490680
TERMINATED Phase 4

Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)

NCT05228184
COMPLETED Phase 3

Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants with Minor Soft Tissue Injury

NCT05171673
COMPLETED Phase 4

Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

NCT03094416
COMPLETED Phase 4

Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries

NCT02132247
COMPLETED Phase 3

Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF)

NCT00828191
COMPLETED Phase 3

Clinical Efficacy and Tolerability of Two FSH Preparations (Human FSH Versus rFSH - Follitropin Alpha) in Women Undergoing IVF

NCT00378001

Phase Distribution

PhaseTrial count
Phase 3 5
Phase 4 3

Therapeutic Areas

Athletic Injuries 1
Infertility 1

How the IBSA Institut Biochimique archive is shaped

8 indexed studies, none listed as recruiting (0% open); 6 completed (75%).

Phase mix: 8 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Athletic Injuries (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

IBSA Institut Biochimique: archived-pipeline peers nationwide

Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

IBSA Institut Biochimique sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share IBSA Institut BiochimiqueAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10xBio22nd Century Group23andMe3-C Institute for Social Development
IBSA Institut Biochimique sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

IBSA Institut Biochimique sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this IBSA Institut Biochimique page

8 registered trials is a research-attention snapshot, not an endorsement of IBSA Institut Biochimique or any single study.

  • None of IBSA Institut Biochimique's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Athletic Injuries is the condition IBSA Institut Biochimique studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Athletic Injuries trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

IBSA Institut Biochimique pipeline card: 8 registered trials from official public datasets.Report a data error.